Evidence map›Paper›PMID 22280885›Full record

ReviewCurrent opinion in microbiology2012

Recent advances in pneumococcal peptidoglycan biosynthesis suggest new vaccine and antimicrobial targets.

Lok-To Sham, Ho-Ching T Tsui, Adrian D Land, Skye M Barendt, Malcolm E Winkler

Abstract readReview
In one paragraph

Review in Current opinion in microbiology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed
6.2field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

39 citing papers in PubMed, 70 citations in OpenAlex.

  1. Elongasome core proteins and class A PBP1a display zonal, processive movement at the midcell ofProceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  2. Article
  3. Review
  4. Article
  5. Expanded profiling ofBiological chemistry · 2022
    Article
  6. Peptidoglycan-based immunomodulation.Applied microbiology and biotechnology · 2022
    Review
  7. Article
  8. The Cell Wall ofMicrobiology spectrum · 2019
    Review
  9. Article
  10. Outer membrane vesicles for vaccination and targeted drug delivery.Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology · 2019
    Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Phosphorylation-dependent activation of the cell wall synthase PBP2a inProceedings of the National Academy of Sciences of the United States of America · 2018
    Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Lok-To ShamDepartment of Biology, Indiana University Bloomington, Bloomington, IN 47405, United States.
Ho-Ching T Tsui
Adrian D Land
Skye M Barendt
Malcolm E Winkler
Indiana University Bloomington · US

Funding

TRAINING IN GENETICST32GM007757 · NIGMS · TRUSTEES OF INDIANA UNIVERSITY · PI KUMAR, JUSTIN P · 1985 to 2014
$8.1M
Signal Transduction by Essential VicRKX in PneumococcusR01AI060744 · NIAID · TRUSTEES OF INDIANA UNIVERSITY · PI WINKLER, MALCOLM E. · 2006 to 2010
$1.8M
Defining PcsB: Essential Murein Biosynthesis Protein in Pathogenic PneumococciF31GM082090 · NIGMS · TRUSTEES OF INDIANA UNIVERSITY · PI BARENDT, SKYE · 2007 to 2009
$116k
NIAID NIH HHS R01 AI060744NIAID NIH HHS R01AI060744NIGMS NIH HHS F31 GM082090NIGMS NIH HHS T32 GM007757NIGMS NIH HHS T32GM007757PHS HHS F31FM082090
6 · The paper itself

Abstract

Streptococcus pneumoniae is a serious human respiratory pathogen that has the capacity to evade capsule-based vaccines and to develop multidrug antibiotic resistance. This review summarizes recent advances in understanding the mechanisms and regulation of peptidoglycan (PG) biosynthesis that result in ellipsoid-shaped, ovococcus Streptococcus cells. New results support a two-state model for septal and peripheral PG synthesis at mid-cell, involvement of essential cell division proteins in PG remodeling, and mid-cell localization of proteins that organize PG biosynthesis and that form the protein translocation apparatus. PG biosynthesis proteins have already turned up as promising vaccine candidates and targets of antibiotics. Properties of several recently characterized proteins that mediate or regulate PG biosynthesis suggest a source of additional targets for therapies against pneumococcus.

Indexed as

Anti-Bacterial AgentsBacterial ProteinsGene Expression Regulation, BacterialHumansPeptidoglycanPneumococcal InfectionsPneumococcal VaccinesStreptococcus pneumoniaeAnti-Bacterial AgentsBacterial ProteinsPeptidoglycanPneumococcal Vaccines

Identifiers

PMID22280885
PMCPMC3322672
OpenAlexW2072872900

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.